SubtlePET™

AI solution for PET scan optimization

SubtlePET™ is an AI solution that enables nuclear medicine centres to reduce acquisition time on existing machines or reduce the dose injected.

For nuclear medicine specialists, improving diagnosis and treatment necessarily requires continuously optimised image quality. This requirement means finding a sometimes difficult balance between diagnostic accuracy, patient comfort and budgetary constraints. From a noisy image, SubtlePET™ corrects and resends an image with a quality equivalent to that of an image obtained under standard acquisition conditions, directly to the interpretation tools.

Validated for a large number of tracers

SubtlePET™ is intended for use with PET images acquired using the following radiotracers: 18F-FDG, 18F-amyloid, 18F-DOPA, 18F-Choline, 18F-DCFPyL, Ga-68 Dotatate, and Ga-68 PSMA.

Reduced acquisition time

SubtlePET™ can increase the quality of images acquired faster. The resubmitted SubtlePET™ image is of standard clinical quality.

Reduction of the injected dose

SubtlePET™ makes it possible to increase the quality of the images
obtained with a lower injected dose². The SubtlePET™ resubmitted image is of standard clinical quality

Compatible with most PET scanner models

SubtlePET™ delivers the enhanced PET series directly into the nuclear medicine specialist’s interpretation tool and thus integrates seamlessly into the existing infrastructure.

Improve the flexibility of your service in manage unforeseen events or needs (machine breakdowns, delivery times, add patient...) more easily

Improve patient comfort and experience by reducing the time spent at the machine

Optimize the use of more expensive tracers (18F-DCFPyL, 18F-DOPA, 18F-amyloid,...)

Save time, secure your diagnosis and optimize your workflow with Incepto

Request a demo

Publications

Clinical and phantom validation of a deep learning based denoising algorithm for F‑18‑FDG PET images from lower detection counting in comparison with the standard acquisition - EJNMMI Physics (2022). DOI:10.1186/s40658-022-00465-z
Artificial intelligence for reduced dose 18F-FDG PET examinations: a real-world deployment through a standardized framework and business case assessment. EJNMMI Physics, 2021. DOI: 10.1186/s40658-021-00374-7
Artificial intelligence‑based PET denoising could allow a two‑fold reduction in [18F]FDG PET acquisition time in digital PET/CT. EJNMMI 2021 - DOI :10.1007/s00259-022-05800-1

Regulatory

SubtlePET™ medical device is a regulated health product that bears the CE mark, Class IIa. Notified bodie: Intertek Medical Notified Body n°2862. Manufacturer: Subtle Medical. SubtlePET™ is a diagnostic tool and shall not be used alone to recommend medical care for diagnostic purposes. Please read the instructions in the user manual carefully. Please contact contact@incepto-medical.com for more information. Last update: 2024/11/27

Contact us to know if this product is available in your country.

Publisher

Subtle Medical was born out of Stanford University by founders, Greg Zaharchuk, MD, Ph.D., Neuroradiologist and Professor at Stanford, and Enhao Gong, Ph.D., a deep learning scientist. Subtle Medical has over 50 full time employees and has been deployed on hundreds of scanners in multiple countries across the globe. Subtle Medical is a healthcare technology company that provides AI-powered medical imaging. Its products, SubtlePET and SubtleMR, are FDA Cleared and CE Marked AI product that enhances images in PET and MR exams aimed for faster & safer workflow.